Nobuko Horiuchi Selected Research

Stroke (Strokes)

12/2007

Continuous inhibition of 20-HETE synthesis by TS-011 improves neurological and functional outcomes after transient focal cerebral ischemia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nobuko Horiuchi Research Topics

Disease

1	Glioblastoma (Glioblastoma Multiforme) 01/2009
1	Neoplasms (Cancer) 01/2009
1	Pain (Aches) 01/2009
1	Prostatic Neoplasms (Prostate Cancer) 01/2009
1	Cancer Pain 01/2009
1	Adenocarcinoma of Lung 01/2009
1	Adenocarcinoma 01/2009
1	Astrocytoma (Pilocytic Astrocytoma) 01/2009
1	Breast Neoplasms (Breast Cancer) 01/2009
1	Bruxism 01/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2009
1	Stroke (Strokes) 12/2007
1	Ischemic Stroke 12/2007
1	Brain Ischemia (Cerebral Ischemia) 12/2007

Drug/Important Bio-Agent (IBA)

1	Integrin alpha5beta1IBA 01/2009
1	Substance PIBA 01/2009
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2009
1	Dehydroepiandrosterone (DHEA)IBA 01/2009
1	N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamideIBA 12/2007
1	20-hydroxy-5,8,11,14-eicosatetraenoic acidIBA 12/2007